Ausgabe 10/2023
Inhalt (38 Artikel)
Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data
Ferda Can, Keziban Naz Yılmaz, Ozge Soyer Kösemehmetoglu, Sema Akıncı, Tekin Güney
Association between anemia and depression: results from NHANES 2005–2018 and mendelian randomization analyses
Yashan Wang, Dingjie Guo, Chuanying Sui, Zihan Qu, Guangliang He, Hengyu Meng, Yuqing Duan, Xin Zhang, Linwei Lan, Chunpeng Wang, Xin Liu
Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions
Vaishali Deenadayalan, Rafaella Litvin, Jay Vakil, Philip Kanemo, Hafeez Shaka, Akash Venkataramanan, Maryam Zia
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study
Qunxiang Qiu, Dan Li, Ying Chen, Ying Song, Shifeng Lou, Kang Zhou, Jianchuan Deng
Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia
Anjali Shah, Chandan Kumar, Chandrakala Shanmukhaiah, Aruna Rajendran, Sangeeta Mudaliar, Susan Idicula-Thomas, Babu Rao Vundinti
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
Wenbing Duan, Sen Yang, Ting Zhao, Lijuan Hu, Yazhen Qin, Jinsong Jia, Jing Wang, Shengye Lu, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Yueyun Lai, Hongxia Shi, Xiaojun Huang, Qian Jiang
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era
Feiyang Qi, Mei Bao, Hanlin Gao, Xiaoshuai Zhang, Shasha Zhao, Chenglei Wang, Wenwen Li, Qian Jiang
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension
Olga Mulas, Brunella Mola, Alessandro Costa, Francesca Pittau, Daniela Mantovani, Samuele Dessì, Antonella Fronteddu, Giorgio La Nasa, Giovanni Caocci
A novel germline hyperactivating JAK2 mutation L604F
Lukáš Dvořáček, Jana Marková, Aleš Holoubek, Dana Grebeňová, David Kundrát, Kateřina Kuželová, Jiří Schwarz
Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
Andrea Corbingi, Rossana Putzulu, Giuseppina Massini, Maria Colangelo, Gessica Minnella, Patrizia Chiusolo, Simona Sica, Nicola Piccirillo
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
Susanne Isfort, Kirsi Manz, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R. Göthert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H. Brümmendorf
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Ethan A. Burns, Justin J. Wilson, Sunil Mathur, Ryan Kieser, Zimu Gong, Chih-Chi Andrew Hu, Chih-Hang Anthony Tang, Jenny Petkova, Carrie Yuen, Hanh Mai, Shilpan Shah, Lawrence Rice, Siddhartha Ganguly, Sai Ravi Pingali
A prediction model for severe hematological toxicity of BTK inhibitors
Dan Jiang, Zaiwei Song, Peng Liu, Zeyuan Wang, Rongsheng Zhao
Role of body composition and metabolic parameters extracted from baseline 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma
Yang Chen, Zhijian Chen, Xiaoyue Tan, Qing Zhang, Yongrong Zhou, Hui Yuan, Lei Jiang
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
Luca Fischer, Linmiao Jiang, Joerg Thomas Bittenbring, Kai Huebel, Christian Schmidt, Johannes Duell, Bernd Metzner, Juergen Krauter, Bertram Glass, Andreas Huettmann, Kerstin Schaefer-Eckart, Elisabeth Silkenstedt, Wolfram Klapper, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling, Eva Hoster
Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series
Yue-Hua Zhang, Zheng Li, Sha Zhao, Wen-Yan Zhang, Qing-Lin Liu, Wei-Ping Liu, Li-Min Gao
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
Lilian Goveia, Nelson Castro, Carmino de Souza, Carolina Colaço Villarim, Fabiola Traina, Carlos Sergio Chiattone, Monica Praxedes, Cristiana Solza, Leila Perobelli, Otavio Baiocchi, Rafael Gaiolla, Carla Boquimpani, Valeria Buccheri, Caroline Bonamin Sola, Roberta de Oliveira Paula e Silva, Ana Carolina Ribas, Giovanna Steffenello, Katia Pagnano, Andrea Soares, Samuel Souza Medina, Talita Silveira, Karin Zattar Cecyn, Leonardo Carvalho Palma, Mariana de Oliveira Marques, Nelson Spector, Irene Biasoli
Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin Lymphoma
Agurne García-Baztán, Mari Cruz Viguria-Alegria, Maria Fernanda Ramón-Espinoza, Ibai Tamayo-Rodríguez, Nancy Jeanette Gonzales-Montejo, Nicolás Martínez-Velilla, Julio Oteiza-Olaso
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India
Nirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V. Velagala, Venkata Rama Mohan Gollamudi, Jayesh Agiwale, Chetan Dhamne, Akanksha Chichra, Shyam Srinivasan, Dhanlaxmi Shetty, Hemani Jain, Papagudi G. Subramanian, Prashant Tembhare, Gaurav Chatterjee, Nikhil Patkar, Gaurav Narula, Shripad Banavali
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma
Chen Gong, Jiazhuo Wu, Wenting Song, Hongwen Li, Cunzhen Shi, Yuyang Gao, Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease
Qing He, Xuelin Dou, Yang Liu, Lei Wen, Fengrong Wang, Nan Peng, Lizhong Gong, Yue Li, Yao Lu, Liru Wang, Xiaohui Zhang, Xiaojun Huang, Jin Lu
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
Jiapei Liu, Zhiping Fan, Na Xu, Jieyu Ye, Yanqiu Chen, Ruoyang Shao, Yiming Sun, Qiaoyuan Wu, Qifa Liu, Hua Jin
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
Hiroaki Araie, Yasuyuki Arai, Michiko Kida, Jun Aoki, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Yukiyasu Ozawa, Masashi Sawa, Yuta Katayama, Yayoi Matsuo, Makoto Onizuka, Yoshinobu Kanda, Toshiro Kawakita, Junya Kanda, Yoshiko Atsuta, Masamitsu Yanada
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial
Naoki Kurita, Hidekazu Nishikii, Yumiko Maruyama, Yasuhito Suehara, Keiichiro Hattori, Tatsuhiro Sakamoto, Takayasu Kato, Yasuhisa Yokoyama, Naoshi Obara, Kazushi Maruo, Tomohiro Ohigashi, Hitomi Yamaguchi, Toshiro Iwamoto, Hideto Minohara, Ryota Matsuoka, Koichi Hashimoto, Mamiko Sakata-Yanagimoto, Shigeru Chiba
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
Anjali Cremer, Julius C. Enssle, Saskia Pfaff, Khouloud Kouidri, Fabian Lang, Christian Brandts, Andreas Zeiher, Sebastian Cremer, Björn Steffen, Hubert Serve, Gesine Bug
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
Tomoki Iemura, Tadakazu Kondo, Atsushi Ueda, Takeshi Maeda, Toshio Kitawaki, Yasuyuki Arai, Junya Kanda, Takashi Ikeda, Kazunori Imada, Takayuki Ishikawa, Naoyuki Anzai, Mitsuru Itoh, Tomoharu Takeoka, Takashi Akasaka, Kazuhiro Yago, Akihito Yonezawa, Nobuyoshi Arima, Toshiyuki Kitano, Masaharu Nohgawa, Mitsumasa Watanabe, Toshinori Moriguchi, Kouhei Yamashita, Yasunori Ueda, Kana Matsumoto, Akifumi Takaori-Kondo
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region
Alessia Sticchi Damiani, Antonella Zizza, Federico Banchelli, Maddalena Gigante, Maria Lucia De Feo, Angelo Ostuni, Valerio Marinelli, Serena Quagnano, Pierpaolo Negro, Nicola Di Renzo, Marcello Guido
Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis
Xinyue Chen, Juan Xiao, Xinwei Wang, Xinyi Lu, Jing An, Jie Zhao, Junni Wei, Jia Wei, Shaolong He, Weiwei Tian
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
Mengru Tian, Xinyue Liang, Weiling Xu, Xingcheng Yi, Tingting Yue, Yingjie Zhang, Shanshan Yu, Yurong Yan, Zhongli Hu, Nan Zhang, Jingxuan Wang, Rui Hu, Xiaoxiao Sun, Yuanyuan Nie, Yun Dai, Fengyan Jin
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3
Yukiko Komeno, Toru Uchiyama, Fuyuko Kawano, Yuya Kurihara, Mineo Kurokawa, Osamu Ohara, Shinji Kunishima, Akira Ishiguro
Successful treatment of systemic mastocytosis with acute myeloid leukemia: a case report
Minran Zhou, Guangcai Zhong, Yuan Yu, Ran Wang, Sai Ma, Chunyan Chen
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
Jian Li, Chunyan Cao, Shifeng Lu, LiuCheng Rong, Meiyun Kang, Yongjun Fang
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
Toyoshi Yanagihara, Kentaro Hata, Keisuke Matsubara, Kazufumi Kunimura, Kunihiro Suzuki, Kazuya Tsubouchi, Satoshi Ikegame, Yoshihiro Baba, Yoshinori Fukui, Isamu Okamoto
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
Alice Di Rocco, Martina Di Palma, Gianna Maria D’Elia, Giovanni Iaquinta, Massimo Breccia, Francesca Mancini, Paola Grammatico, Maurizio Martelli
Real-life experience with luspatercept in transfusion-dependent β-thalassemia
Daniela Roccotelli, Domenica Grande, Gerolamo Cicco, Antonio Palma, Maria C. Longo, Francesco Albano, Angelantonio Vitucci, Pellegrino Musto
One disease, two faces: clonally-related AML and MPDCP with skin involvement
Giovanni Martino, Gaetano Cimino, Matteo Caridi, Giuseppe Perta, Valeria Cardinali, Sofia Sciabolacci, Martina Quintini, Caterina Matteucci, Alessandra Venanzi, Enrico Tiacci, Stefano Ascani, Cristina Mecucci, Maria Paola Martelli
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases
Yupeng Wang, Zi Wang, Chong Wei, Danqing Zhao, Yan Zhang, Wei Wang, Wei Zhang, Daobin Zhou
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma
A. Rago, G. Palumbo, A. Tordi, S. Bianchi, M. Offidani, T. Caravita di Toritto